publication venue for
- Follicular Dendritic Cell Sarcoma of Uterine Corpus: Report of 2 Cases. 2022
- Metastatic Uterine Leiomyosarcoma With Rhabdomyosarcomatous Heterologous Differentiation. 2022
- High-grade Endometrial Carcinoma With Serous and Colorectal Carcinoma-like Components: Unique Morphology in Correlation With Immunohistochemical and Molecular Findings. 2024
- HER2/ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors. 2023
- Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. 2021
- Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.. 39. 2020
- Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).. 38. 2019
- International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group.. 38 Suppl 1. 2019
- Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.. 37. 2018
- Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas.. 36. 2017
- Incidental Serous Tubal Intraepithelial Carcinoma and Non-Neoplastic Conditions of the Fallopian Tubes in Grossly Normal Adnexa: A Clinicopathologic Study of 388 Completely Embedded Cases.. 35. 2016
- Value of PAX-8 and SF-1 Immunohistochemistry in the Distinction Between Female Adnexal Tumor of Probable Wolffian Origin and its Mimics.. 35. 2016
- Application of p16 Immunohistochemistry and RNA In Situ Hybridization in the Classification of Adenoid Basal Tumors of the Cervix.. 35. 2016
- Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.. 35. 2016
- Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.. 34. 2015
- Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.. 33. 2014
- PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.. 33. 2014
- PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma).. 33. 2014
- An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas.. 32. 2013
- Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin.. 32. 2013
- Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma.. 31. 2012
- The fallopian tube-peritoneal junction: a potential site of carcinogenesis.. 30. 2011
- Prognostic factors for stage I ovarian carcinoma.. 29. 2010
- Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.. 27. 2008
- Fetal polymorphisms in anti-inflammatory cytokine and beta-adrenergic receptor genes associated with placental pathological lesions.. 27. 2008
- A fetal cyclooxygenase-2 gene polymorphism is associated with placental malperfusion.. 26. 2007
- Venous thrombosis in the broad ligament: is it a predictor of postoperative pulmonary embolism in gynecological cancer patients? A case-control study.. 23. 2004
- Extrauterine lesions of intermediate trophoblast.. 22. 2003
- Cyclin D1 expression in high-grade endometrial carcinomas--association with histologic subtype.. 19. 2000
- High-grade sarcoma masquerading as growing teratoma syndrome after resection of ovarian immature teratoma: report of a case. 2012